Last reviewed · How we verify
GPur- Luminating Oral Cholesterol Kinetics Pilot Study (GLOCK-pilot)
In healthy subjects not receiving or requiring lipid lowering therapy and who do not have diabetes, the use of clinoptilolite (GPUR) will result in a reduction of absorbed dietary cholesterol observed over 6 days of therapy.
Details
| Lead sponsor | Canadian Collaborative Research Network |
|---|---|
| Phase | NA |
| Status | COMPLETED |
| Enrolment | 22 |
| Start date | Thu Jun 01 2017 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Mon Jan 15 2018 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Cholesterol Absorption
Interventions
- clinoptilolite
Countries
United States